You are currently viewing Side branch patency after implantation of the novel DESolve bi oresorbable vascular scaffold system in the treatment of de novo coronary lesions

Side branch patency after implantation of the novel DESolve bi oresorbable vascular scaffold system in the treatment of de novo coronary lesions

EBC - ON DEMAND

Side branch patency after implantation of the novel DESolve bi oresorbable vascular scaffold system in the treatment of de novo coronary lesions

European Bifurcation Club 2014 – EBC 2014 – Bordeaux, France

Cases: tips & tricks and complications

Side branch patency after implantation of the novel DESolve bioresorbable vascular scaffold system in the treatment of de novo coronary lesions

Author: Ricardo A. Costa, Cardiovascular Research Center, Sao Paulo, SP, Brazil

 

OBJECTIVE

Our aim was to investigate the occurrence of SB occlusion after implantation of the novel DESolve bioresorbable scaffold device in single de novo coronary lesions

CONCLUSION

In the prospective, non-randomized, single-arm, multicenter DESolve Nx trial, SB occlusion – as determined by final TIMI flow < 2, after implantation of the novel DESolve bioresorbable vascular scaffold was relatively low (4%) and was not associated with adverse clinical events during index hospitalization.

 

Download here

 

Leave a Reply